1. A case of latanoprost‐induced diffuse facial skin hyperpigmentation
- Author
-
Joong Heon Suh, Un Ha Lee, Ho-Young Kim, Myoung Shin Kim, Soo-Kyung Lee, and Jae-Ho Lee
- Subjects
medicine.medical_specialty ,genetic structures ,Biopsy ,Glaucoma ,Administration, Ophthalmic ,Skin Pigmentation ,Lasers, Solid-State ,Dermatology ,Administration, Cutaneous ,030207 dermatology & venereal diseases ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Dermis ,Hyperpigmentation ,medicine ,Humans ,Low-Level Light Therapy ,Latanoprost ,Adverse effect ,Antihypertensive Agents ,Aged ,Skin ,Facial hyperpigmentation ,medicine.diagnostic_test ,Drug Substitution ,business.industry ,medicine.disease ,eye diseases ,Facial skin ,Treatment Outcome ,medicine.anatomical_structure ,chemistry ,Brimonidine Tartrate ,Face ,030220 oncology & carcinogenesis ,Female ,Dermatologic Agents ,sense organs ,Ophthalmic Solutions ,medicine.symptom ,business - Abstract
Introduction Latanoprost is a prostaglandin F2α analogue, which has been used as a first-line drug for open-angle glaucoma. Common side effects of latanoprost include hyperpigmentation. While it usually occurs on irides or periocular skin, diffuse facial hyperpigmentation is rarely reported. Case presentation A 71-year-old woman was presented with diffuse gray-brown colored maculopatches on her face. The symptom appeared 1 week after she started to use latanoprost eye drops for glaucoma. Biopsy specimen revealed vacuolar degeneration of dermo-epidermal junction and pigment incontinence in dermis. Objective The aim of this paper is to introduce a rare adverse effect of latanoprost and effective way of treatment. Methods We stopped her from using latanoprost. She was also treated with 532-nm potassium titanyl phosphate laser and low-fluence 1064-nm Q-switched Nd:YAG laser, while using topical agents. Result After 10 weeks, we observed hyperpigmentation of her face was effectively and safely treated. The patient was satisfied with the result. Conclusion Diffuse facial pigmentation could be one of the latanoprost-induced adverse effects and the laser treatments with topical agents we used can make it improve faster.
- Published
- 2019